Pharmacovigilance Market Size, Share & Industry Analysis, By Type (Service and Software), By Deployment (In-house and Outsource), By End-User (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI102746

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Snapshot of Rate of Adverse Drug Reactions – By Key Region/Countries
2. Regulatory Scenario in the Pharmacovigilance Industry
3. Overview of Government Initiatives in Safe Medicine Use
4. Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.)
5. Impact of COVID-19 on the Market
Global Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Type
  2. U.K.
    1. By Type
  3. France
    1. By Type
  4. Italy
    1. By Type
  5. Spain
    1. By Type
  6. Rest of Europe
    1. By Type
Asia Pacific Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Type
  2. Japan
    1. By Type
  3. India
    1. By Type
  4. Australia
    1. By Type
  5. Southeast Asia
    1. By Type
  6. Rest of Asia Pacific
    1. By Type
Latin America Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
    1. By Type
  2. Mexico
    1. By Type
  3. Rest of Latin America
    1. By Type
Middle East & Africa Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
    1. By Type
  2. South Africa
    1. By Type
  3. Rest of Middle East & Africa
    1. By Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. IQVIA Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Labcorp Drug Development
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Parexel International Corporation
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Accenture
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Cognizant
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Ergomed Group
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Thermo Fisher Scientific Inc. (Pharmaceutical Product Development, LLC)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. ICON plc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Quanticate
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Snapshot of Rate of Adverse Drug Reactions – By Key Region/Countries
2. Regulatory Scenario in the Pharmacovigilance Industry
3. Overview of Government Initiatives in Safe Medicine Use
4. Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.)
5. Impact of COVID-19 on the Market
Global Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Type
  2. U.K.
    1. By Type
  3. France
    1. By Type
  4. Italy
    1. By Type
  5. Spain
    1. By Type
  6. Rest of Europe
    1. By Type
Asia Pacific Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Type
  2. Japan
    1. By Type
  3. India
    1. By Type
  4. Australia
    1. By Type
  5. Southeast Asia
    1. By Type
  6. Rest of Asia Pacific
    1. By Type
Latin America Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
    1. By Type
  2. Mexico
    1. By Type
  3. Rest of Latin America
    1. By Type
Middle East & Africa Pharmacovigilance Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Service
  2. Software
2. Market Analysis, Insights and Forecast – By Deployment
  1. In-house
  2. Outsource
3. Market Analysis, Insights and Forecast – By End User
  1. Contract Research Organizations (CROs)
  2. Pharmaceutical & Biotechnology Companies
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
    1. By Type
  2. South Africa
    1. By Type
  3. Rest of Middle East & Africa
    1. By Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. IQVIA Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Labcorp Drug Development
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Parexel International Corporation
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Accenture
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Cognizant
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Ergomed Group
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Thermo Fisher Scientific Inc. (Pharmaceutical Product Development, LLC)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. ICON plc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Quanticate
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Pharmacovigilance Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034

Figure 02: Global Pharmacovigilance Market Value Share (%), By Type, 2025 & 2034

Figure 03: Global Pharmacovigilance Market Value Share (%), By Deployment, 2025 & 2034

Figure 04: Global Pharmacovigilance Market Value Share (%), By End User, 2025 & 2034

Figure 05: Global Pharmacovigilance Market Value Share (%), By Region, 2025 & 2034

Figure 06: North America Pharmacovigilance Market Value (USD billion), by Type, 2025 & 2034

Figure 07: North America Pharmacovigilance Market Value Share (%), by Type, 2025

Figure 08: North America Pharmacovigilance Market Value (USD billion), by Deployment, 2025 & 2034

Figure 09: North America Pharmacovigilance Market Value Share (%), by Deployment, 2025

Figure 10: North America Pharmacovigilance Market Value (USD billion), by End User, 2025 & 2034

Figure 11: North America Pharmacovigilance Market Value Share (%), by End User, 2025

Figure 12: North America Pharmacovigilance Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Pharmacovigilance Market Value Share (%), By Country, 2025

Figure 14: Europe Pharmacovigilance Market Value (USD billion), by Type, 2025 & 2034

Figure 15: Europe Pharmacovigilance Market Value Share (%), by Type, 2025

Figure 16: Europe Pharmacovigilance Market Value (USD billion), by Deployment, 2025 & 2034

Figure 17: Europe Pharmacovigilance Market Value Share (%), by Deployment, 2025

Figure 18: Europe Pharmacovigilance Market Value (USD billion), by End User, 2025 & 2034

Figure 19: Europe Pharmacovigilance Market Value Share (%), by End User, 2025

Figure 20: Europe Pharmacovigilance Market Value (USD billion), By Country/Sub-Region, 2025 & 2034

Figure 21: Europe Pharmacovigilance Market Value Share (%), By Country/Sub-Region, 2025

Figure 22: Asia Pacific Pharmacovigilance Market Value (USD billion), by Type, 2025 & 2034

Figure 23: Asia Pacific Pharmacovigilance Market Value Share (%), by Type, 2025

Figure 24: Asia Pacific Pharmacovigilance Market Value (USD billion), by Deployment, 2025 & 2034

Figure 25: Asia Pacific Pharmacovigilance Market Value Share (%), by Deployment, 2025

Figure 26: Asia Pacific Pharmacovigilance Market Value (USD billion), by End User, 2025 & 2034

Figure 27: Asia Pacific Pharmacovigilance Market Value Share (%), by End User, 2025

Figure 28: Asia Pacific Pharmacovigilance Market Value (USD billion), By Country/Sub-Region, 2025 & 2034

Figure 29: Asia Pacific Pharmacovigilance Market Value Share (%), By Country/Sub-Region, 2025

Figure 30: Latin America Pharmacovigilance Market Value (USD billion), by Type, 2025 & 2034

Figure 31: Latin America Pharmacovigilance Market Value Share (%), by Type, 2025

Figure 32: Latin America Pharmacovigilance Market Value (USD billion), by Deployment, 2025 & 2034

Figure 33: Latin America Pharmacovigilance Market Value Share (%), by Deployment, 2025

Figure 34: Latin America Pharmacovigilance Market Value (USD billion), by End User, 2025 & 2034

Figure 35: Latin America Pharmacovigilance Market Value Share (%), by End User, 2025

Figure 36: Latin America Pharmacovigilance Market Value (USD billion), By Country/Sub-Region, 2025 & 2034

Figure 37: Latin America Pharmacovigilance Market Value Share (%), By Country/Sub-Region, 2025

Figure 38: Middle East & Africa Pharmacovigilance Market Value (USD billion), by Type, 2025 & 2034

Figure 39: Middle East & Africa Pharmacovigilance Market Value Share (%), by Type, 2025

Figure 40: Middle East & Africa Pharmacovigilance Market Value (USD billion), by Deployment, 2025 &2034

Figure 41: Middle East & Africa Pharmacovigilance Market Value Share (%), by Deployment 2025

Figure 42: Middle East & Africa Pharmacovigilance Market Value (USD billion), by End User, 2025 & 2034

Figure 43: Middle East & Africa Pharmacovigilance Market Value Share (%), by End User, 2025

Figure 44: Middle East & Africa Pharmacovigilance Market Value (USD billion), By Country/Sub-Region, 2025 & 2034

Figure 45: Middle East & Africa Pharmacovigilance Market Value Share (%), By Country/Sub-Region, 2025

Figure 46: Global Pharmacovigilance Market Share (%), By Company, 2025

List of Tables

Table 01: Global Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 02: Global Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 03: Global Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 04: Global Pharmacovigilance Market Revenue (USD billion) Forecast, By Region, 2021–2034

Table 05: North America Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 06: North America Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 07: North America Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 08: North America Pharmacovigilance Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 09: U.S. Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 10: Canada Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 11: Europe Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 12: Europe Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 13: Europe Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 14: Europe Pharmacovigilance Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 15: Germany Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 16: U.K Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 17: France Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 18: Italy Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 19: Spain Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 20: Rest of Europe Pharmacovigilance Market Revenue (USD billion) Forecast, By Type,

Table 21: Asia Pacific Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 22: Asia Pacific Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 23: Asia Pacific Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 24: Asia Pacific Pharmacovigilance Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 25: China Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 26: Japan Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 27: India Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 28: Australia Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 29: Southeast Asia Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 30: Rest of Asia Pacific Pharmacovigilance Market Revenue (USD billion) Forecast, By

Table 31: Latin America Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 32: Latin America Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 33: Latin America Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 34: Latin America Pharmacovigilance Market Revenue (USD billion) Forecast, By

Table 35: Brazil Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 36: Mexico Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 37: Rest of Latin America Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 38: Middle East & Africa Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 39: Middle East & Africa Pharmacovigilance Market Revenue (USD billion) Forecast, By Deployment, 2021–2034

Table 40: Middle East & Africa Pharmacovigilance Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 41: Middle East & Africa Pharmacovigilance Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 42: GCC Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 43: South Africa Pharmacovigilance Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 44: Rest of Middle East & Africa Pharmacovigilance Market Revenue (USD billion)

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 149

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com